JAK2 and cardiac hypertrophy: The activation of the JAK2/STAT3 signaling pathway was detected in hypertrophic hearts elicited by isoproterenol (51, 52) and the inhibition of the activities of JAK2 and STAT3 mitigated myocardial hypertrophy (53).